4.6 out of 5 (94 Reviews)



Post Assessment Questions


Start Date

1 Sep 2023

Last Review Date

12 Nov 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes

Need Help?  If you have a system or content concerns, please contact

Activity Description

Alendronate is approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis, steroid-induced osteoporosis, and male osteoporosis, as well as for the management of Paget disease of bone. Alendronate belongs to the class of bisphosphonate medications, which aids in the prevention of bone resorption and the promotion of bone density, making it a valuable treatment for osteoporosis and various other bone-related conditions. By binding to hydroxyapatite crystals within bone, alendronate downregulates osteoclast-mediated bone reabsorption, thereby leading to a reduction in bone matrix breakdown. Both of these mechanisms collectively contribute to regulating the reabsorption and turnover of minerals. This activity provides a comprehensive review of alendronate, including its indications, mechanism of action, specific patient populations, potential adverse effects, and the significance of monitoring during its administration. This activity also highlights the essential collaborative approach among interprofessional healthcare professionals for the effective treatment and prevention of osteoporosis.

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the appropriate patient populations and conditions for which alendronate is indicated, including postmenopausal osteoporosis, steroid-induced osteoporosis, male osteoporosis, and Paget disease of bone.

  • Screen patients for contraindications and risk factors affecting alendronate therapy, such as esophageal abnormalities, delayed esophageal emptying, and hypocalcemia.

  • Apply knowledge of alendronate's mechanism of action to tailor treatment plans for specific patient needs, considering factors such as age, gender, and fracture risk.

  • Collaborate with other healthcare professionals to provide comprehensive education on alendronate therapy, potential adverse effects, and the importance of medication adherence for optimal patient outcomes.


StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Pediatrics: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact


This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.




Lori W. on 6/18/2021

William B. on 8/6/2021

John Y. on 8/25/2021

Alana H. on 8/26/2021

Kelsey G. on 8/29/2021

Lisa R. on 10/21/2021

Patrick G. on 10/23/2021

Mary C. on 11/9/2021

Toni h. on 12/31/2021

Trenna R. on 12/31/2021

Georgiann B. on 1/9/2022

john e. on 2/19/2022

Russell R. on 3/10/2022

Michael M. on 3/21/2022

Stephanie B. on 3/31/2022

Michele D. on 5/1/2022

Paul H. on 5/8/2022

Amy R. on 5/6/2022

Jacinta U. on 5/9/2022

Christine D. on 5/11/2022

Shelia C. on 5/16/2022

Deanna K. on 5/22/2022

BURTON L. on 6/25/2022

Grace N. on 6/26/2022

Nancy F. on 6/27/2022

Dawn E. on 7/3/2022

Brittany T. on 8/1/2022

Kaitlin C. on 8/12/2022

Christina L. on 8/14/2022

Clifford A. on 8/24/2022

Alex N. on 8/30/2022

Shanon Z. on 9/4/2022

Rachel E. on 9/18/2022

Matthew S. on 10/22/2022

Charles W. on 11/19/2022

Amr K. on 12/1/2022

Holly J. on 12/14/2022

Kecia T. on 12/21/2022

Kelli M. on 12/22/2022

Rachael F. on 12/27/2022

paula s. on 12/28/2022

Simranjit K. on 12/30/2022

Natalie p. on 1/2/2023

Brenna B. on 1/4/2023

syble c. on 1/14/2023

Florence Y. on 1/16/2023

Li s. on 1/23/2023

Stephanie C. on 1/26/2023

Lisa B. on 1/29/2023

Lea O. on 1/29/2023

brittany l. on 2/1/2023

Bonnie R. on 2/7/2023

Sharon B. on 2/12/2023

Mary Y. on 2/15/2023

Timothy A. on 2/17/2023

Rose F. on 3/1/2023

Stephanie B. on 3/10/2023

Przemyslaw L. on 3/11/2023

Brian B. on 3/13/2023

Rebecca S. on 3/29/2023

Shirley A. on 4/4/2023

Adel s. on 4/7/2023

Quarshiwaa A. on 4/10/2023

IRIS O. on 4/16/2023

Kinga V. on 4/16/2023

Lily L. on 4/30/2023

Amy L. on 5/7/2023

Linda B. on 5/12/2023

Michael K. on 6/9/2023

Christy S. on 6/29/2023

Natalie M. on 7/3/2023

BARBARA L. on 8/5/2023

Mergene T. on 8/5/2023

Whittney H. on 8/7/2023

Allynda H. on 8/29/2023

Katherine E. on 9/1/2023

Blessing O. on 9/5/2023

Michelle G. on 9/8/2023

Ryan H. on 9/16/2023

Elizabeth S. on 9/22/2023

Justin T. on 9/26/2023

Jarrod G. on 9/28/2023

Stephen W. on 10/5/2023

Celynne A. on 10/15/2023

Jami P. on 10/19/2023

Vu H. on 10/19/2023

Kristopher H. on 10/24/2023

Lisa F. on 10/28/2023

Kody S. on 10/31/2023

Ashok V. on 11/6/2023

William S. on 11/12/2023

Shalamar S. on 11/12/2023

Ashley S. on 11/26/2023

Sahar E. on 11/26/2023

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6763 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8032 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$49 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user